OptimizeRx CorporationOPRXNASDAQ
Loading
Year-over-year SG&A expense growth
| Period | Value |
|---|---|
| Q4 2025 | -15.72% |
| Q3 2025 | 0.10% |
| Q2 2025 | 0.06% |
| Q1 2025 | -16.95% |
| Q4 2024 | 28.83% |
| Q3 2024 | -6.64% |
| Q2 2024 | -11.05% |
| Q1 2024 | -14.28% |
| Q4 2023 | 46.35% |
| Q3 2023 | 5.55% |
| Q2 2023 | -12.99% |
| Q1 2023 | -1.58% |
| Q4 2022 | 12.60% |
| Q3 2022 | 2.77% |
| Q2 2022 | 8.16% |
| Q1 2022 | 17.63% |
| Q4 2021 | 19.83% |
| Q3 2021 | 16.58% |
| Q2 2021 | 17.13% |
| Q1 2021 | -17.52% |
| Q4 2020 | 31.45% |
| Q3 2020 | 12.22% |
| Q2 2020 | -17.20% |
| Q1 2020 | -52.45% |
| Q4 2019 | 276.15% |
| Q3 2019 | -1.49% |
| Q2 2019 | 8.05% |
| Q1 2019 | -4.82% |
| Q4 2018 | 20.80% |
| Q3 2018 | 13.01% |
| Q2 2018 | 17.12% |
| Q1 2018 | -23.52% |
| Q4 2017 | 47.85% |
| Q3 2017 | 27.15% |
| Q2 2017 | 1.16% |
| Q1 2017 | -16.18% |
| Q4 2016 | 43.10% |
| Q3 2016 | -11.23% |
| Q2 2016 | 18.61% |
| Q1 2016 | 5.36% |